[1]
|
Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459(7244):262-265. doi: 10.1038/nature07935
|
[2]
|
Idris M, Alves MM, Hofstra RMW, et al. Intestinal multicellular organoids to study colorectal cancer[J]. Biochim Biophys Acta Rev Cancer, 2021, 1876(2):188586. doi: 10.1016/j.bbcan.2021.188586
|
[3]
|
Kopper O, de Witte CJ, Lõhmussaar K, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity[J]. Nat Med, 2019, 25(5):838-849. doi: 10.1038/s41591-019-0422-6
|
[4]
|
Maenhoudt N, Defraye C, Boretto M, et al. developing organoids from ovarian cancer as experimental and preclinical models[J]. Stem Cell Reports, 2020, 14(4):717-729. doi: 10.1016/j.stemcr.2020.03.004
|
[5]
|
Lo Y H, Kolahi K S, Du Y, et al. A CRISPR/Cas9-Engineered ARID1A-deficient human gastric cancer organoid model reveals essential and nonessential modes of oncogenic transformation[J]. Cancer Discov, 2021, 11(6):1562-1581. doi: 10.1158/2159-8290.CD-20-1109
|
[6]
|
Huang W, Navarro-Serer B, Jeong YJ, et al. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome[J]. Cancer Res, 2020, 80(13):2804-2817. doi: 10.1158/0008-5472.CAN-19-1523
|
[7]
|
Rosenbluth JM, Schackmann RCJ, Gray GK, et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages[J]. Nat Commun, 2020, 11(1):1711. doi: 10.1038/s41467-020-15548-7
|
[8]
|
Sampaziotis F, Muraro D, Tysoe OC, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver[J]. Science, 2021, 371(6531):839-846. doi: 10.1126/science.aaz6964
|
[9]
|
Silvestri VL, Henriet E, Linville RM, et al. A tissue-engineered 3D microvessel model reveals the dynamics of mosaic vessel formation in breast cancer[J]. Cancer Res, 2020, 80(19):4288-4301. doi: 10.1158/0008-5472.CAN-19-1564
|
[10]
|
Bartfeld S, Bayram T, van de Wetering M, et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection[J]. Gastroenterology, 2015, 148(1):126-136.e6. doi: 10.1053/j.gastro.2014.09.042
|
[11]
|
McCracken KW, Catá EM, Crawford CM, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids[J]. Nature, 2014, 516(7531):400-404. doi: 10.1038/nature13863
|
[12]
|
Scanu T, Spaapen RM, Bakker JM, et al. Salmonella manipulation of host signaling pathways provokes cellular transformation associated with gallbladder carcinoma[J]. Cell Host Microbe, 2015, 17(6):763-774. doi: 10.1016/j.chom.2015.05.002
|
[13]
|
De Crignis E, Hossain T, Romal S, et al. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma[J]. Elife, 2021, 10:e60747. doi: 10.7554/eLife.60747
|
[14]
|
Lõhmussaar K, Oka R, Espejo Valle-Inclan J, et al. Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer[J]. Cell stem cell, 2021, 28(8):1380-1396. doi: 10.1016/j.stem.2021.03.012
|
[15]
|
Matano M, Date S, Shimokawa M, et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids[J]. Nat Med, 2015, 21(3):256-262. doi: 10.1038/nm.3802
|
[16]
|
Drost J, van Jaarsveld RH, Ponsioen B, et al. Sequential cancer mutations in cultured human intestinal stem cells[J]. Nature, 2015, 521(7550):43-47. doi: 10.1038/nature14415
|
[17]
|
Dekkers JF, Whittle JR, Vaillant F, et al. Modeling breast cancer using CRISPR-Cas9-mediated engineering of human breast organoids[J]. J Natl Cancer Inst, 2020, 112(5):540-544.
|
[18]
|
Chen P, Zhang X, Ding R, et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer[J]. Adv Sci (Weinh), 2021, 8(22):e2101176.
|
[19]
|
Yao Y, Xu X, Yang L, Zhu J, et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer[J]. Cell stem cell, 2020, 26(1):17-26. doi: 10.1016/j.stem.2019.10.010
|
[20]
|
Driehuis E, van Hoeck A, Moore K, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening[J]. Proc Natl Acad Sci U S A, 2019, 116(52):26580-26590.
|
[21]
|
Wensink GE, Elias SG, Mullenders J, et al. Patient-derived organoids as a predictive biomarker for treatment response in cancer patients[J]. NPJ Precis Oncol, 2021, 5(1):30. doi: 10.1038/s41698-021-00168-1
|
[22]
|
Beshiri ML, Tice CM, Tran C, et al. A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening[J]. Clin Cancer Res, 2018, 24(17):4332-4345. doi: 10.1158/1078-0432.CCR-18-0409
|
[23]
|
Pamarthy S, Sabaawy HE. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine[J]. Mol Cancer, 2021, 20(1):125. doi: 10.1186/s12943-021-01426-3
|
[24]
|
Welti J, Sharp A, Yuan W, et al. Targeting bromodomain and extra-terminal (BET) family proteins in castration-resistant prostate cancer (CRPC)[J]. Clin Cancer Res, 2018, 24(13):3149-3162. doi: 10.1158/1078-0432.CCR-17-3571
|
[25]
|
赵冰,宋伟,王海霞.肿瘤类器官诊治平台的质量控制标准中国专家共识(2022年版)[J].中国癌症杂志,2022,32(7):657-68.
|
[26]
|
Neal JT, Li X, Zhu J, et al. Organoid modeling of the tumor immune microenvironment[J]. Cell, 2018, 175(7):1972-1988. doi: 10.1016/j.cell.2018.11.021
|
[27]
|
Dijkstra KK, Cattaneo CM, Weeber F, et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018, 174(6):1586-1598. doi: 10.1016/j.cell.2018.07.009
|
[28]
|
Cattaneo CM, Dijkstra KK, Fanchi LF, et al. Tumor organoid-T-cell coculture systems[J]. Nat Protoc, 2020, 15(1):15-39. doi: 10.1038/s41596-019-0232-9
|
[29]
|
Meng Q, Xie S, Gray GK, et al. Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids[J]. J Immunother Cancer, 2021,9(11):e003213.
|
[30]
|
Schnalzger TE, de Groot MH, Zhang C, et al. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids[J]. EMBO J, 2019, 38(12):e100928
|
[31]
|
van de Wetering M, Francies HE, Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161(4):933-945.
|
[32]
|
Perrone F, Zilbauer M. Biobanking of human gut organoids for translational research[J]. Exp Mol Med, 2021, 53(10):1451-1458.
|